The growing landscape of the India pharmaceuticals is witnessing significant attention on Retatrutide, a innovative dual GIP and GLP-1 target exhibiting efficacy for obesity treatment . This molecule is generating considerable buzz within the healthcare community, particularly as domestic companies investigate licensing agreements . The current … Read More